✦ LIBER ✦

HER2 overexpression as a prognostic factor in metastatic breast cancer patients treated with high-dose chemotherapy and autologous stem cell support

✍ Scribed by Guarneri, V; Bengala, C; Orlandini, C; Gennari, A; Donati, S; Campani, D; Collecchi, P; Maur, M; Conte, P F

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Expression of C-erbB-2/HER-2 in patients

✍ Bewick, M; Chadderton, T; Conlon, M; Lafrenie, R; Morris, D; Stewart, D; Glück, 📂 Article 📅 1999 🏛 Nature Publishing Group 🌐 English ⚖ 70 KB

High dose chemotherapy with autologous s

✍ Lois J. Ayash 📂 Article 📅 1994 🏛 John Wiley and Sons 🌐 English ⚖ 416 KB 👁 1 views

High-dose chemotherapy with autologous s

✍ Ljungman, P; Björkstrand, B; Fornander, T; Höglund, M; Juliusson, G; Lindman, H; 📂 Article 📅 1998 🏛 Nature Publishing Group 🌐 English ⚖ 45 KB

Tandem and triple high-dose chemotherapy

✍ J. Huober; A. Schneeweiss; S. Hohaus; G. Wittmann; A. Meyer; S. Martin; H. Golds 📂 Article 📅 1998 🏛 Springer-Verlag 🌐 English ⚖ 97 KB

High-dose chemotherapy with autologous s

✍ Bojko, P; Welt, A; Schleucher, R; Borquez, D; Scheulen, M E; Vanhoefer, U; Poett 📂 Article 📅 2004 🏛 Nature Publishing Group 🌐 English ⚖ 136 KB

High-dose chemotherapy consolidation wit

✍ Laport, G F; Grad, G; Grinblatt, D L; Bitran, J D; Williams, S F 📂 Article 📅 1998 🏛 Nature Publishing Group 🌐 English ⚖ 81 KB